Nutrition & Care Q3 2021 Sales in the Nutrition & Care segment rose considerably compared with the third quarter of 2020. This was due to considerable sales growth in the Care Chemicals division. Sales in the Nutrition & Health division matched the level of the prior-year quarter. (XLSX:) XLS Factors influencing sales in Q3 2021 – Nutrition & Care Nutrition & Care Care Chemicals Nutrition & Health Volumes 7% 10% 2% Prices 7% 10% 0% Portfolio –2% –2% –2% Currencies 0% 0% 0% Sales 12% 18% 0% The sales performance was mainly attributable to higher volumes in both divisions. Sales volumes in the Care Chemicals division increased especially in the personal care solutions business and in the home care, industrial and institutional cleaning and industrial formulators business. Volumes in the Nutrition & Health division grew primarily in the pharmaceutical business. Overall higher price levels contributed to sales growth. Prices rose in the Care Chemicals division, particularly in the oleo surfactants and fatty alcohols business, as well as in the home care, industrial and institutional cleaning and industrial formulators business. Prices in the Nutrition & Health division matched the level of the prior-year quarter. Portfolio effects from the sale of the production site in Kankakee, Illinois, had a negative impact on sales. The segment’s income from operations (EBIT) before special items was considerably below the level of the prior-year quarter. This was largely due to the significantly lower EBIT before special items in the Nutrition & Health division resulting primarily from lower margins associated with higher raw material and energy prices, which could only be passed on partially. EBIT before special items in the Care Chemicals division decreased slightly due mainly to higher fixed costs. The decline in special items in the third quarter of 2021 was due primarily to the special charges for impairments and provisions in the prior-year quarter. (XLSX:) XLS Segment data – Nutrition & Care (Million €) Q3 January–September 2021 2020 +/– 2021 2020 +/– Sales to third parties 1,598 1,427 12% 4,715 4,564 3% of which Care Chemicals 1,108 938 18% 3,250 3,033 7% Nutrition & Health 490 489 0% 1,465 1,531 –4% Income from operations before depreciation, amortization and special items 206 247 –17% 761 966 –21% Income from operations before depreciation and amortization (EBITDA) 207 230 –10% 815 941 –13% Depreciation and amortizationa 102 144 –29% 301 356 –15% Income from operations (EBIT) 105 86 22% 514 585 –12% Special items 1 –57 . 54 –68 . EBIT before special items 104 143 –27% 460 653 –30% Assets (September 30) 6,911 6,423 8% 6,911 6,423 8% Investments including acquisitionsb 196 130 51% 414 336 23% Research and development expenses 39 41 –5% 122 115 6% a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments) b Additions to property, plant and equipment and intangible assets back next